These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 32842758)
1. Targeting Cardiac Myocyte Na Fry NAS; Liu CC; Garcia A; Hamilton EJ; Karimi Galougahi K; Kim YJ; Whalley DW; Bundgaard H; Rasmussen HH Circ Heart Fail; 2020 Sep; 13(9):e006753. PubMed ID: 32842758 [TBL] [Abstract][Full Text] [Related]
2. β(3) adrenergic stimulation of the cardiac Na+-K+ pump by reversal of an inhibitory oxidative modification. Bundgaard H; Liu CC; Garcia A; Hamilton EJ; Huang Y; Chia KK; Hunyor SN; Figtree GA; Rasmussen HH Circulation; 2010 Dec; 122(25):2699-708. PubMed ID: 21135361 [TBL] [Abstract][Full Text] [Related]
3. β3-Adrenoceptor activation relieves oxidative inhibition of the cardiac Na+-K+ pump in hyperglycemia induced by insulin receptor blockade. Karimi Galougahi K; Liu CC; Garcia A; Fry NA; Hamilton EJ; Figtree GA; Rasmussen HH Am J Physiol Cell Physiol; 2015 Sep; 309(5):C286-95. PubMed ID: 26063704 [TBL] [Abstract][Full Text] [Related]
4. Enhanced inhibition of L-type Ca2+ current by beta3-adrenergic stimulation in failing rat heart. Zhang ZS; Cheng HJ; Onishi K; Ohte N; Wannenburg T; Cheng CP J Pharmacol Exp Ther; 2005 Dec; 315(3):1203-11. PubMed ID: 16135702 [TBL] [Abstract][Full Text] [Related]
5. [Effect of beta3-adrenoreceptors agonist on beta3-adrenoreceptors expression and myocyte apoptosis in a rat model of heart failure]. Kong YH; Li WM; Tian Y Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Mar; 16(3):142-7. PubMed ID: 15009959 [TBL] [Abstract][Full Text] [Related]
6. Protein kinase-dependent oxidative regulation of the cardiac Na+-K+ pump: evidence from in vivo and in vitro modulation of cell signalling. Galougahi KK; Liu CC; Garcia A; Fry NA; Hamilton EJ; Rasmussen HH; Figtree GA J Physiol; 2013 Jun; 591(12):2999-3015. PubMed ID: 23587884 [TBL] [Abstract][Full Text] [Related]
7. Na(+)-K+ pump cycle during beta-adrenergic stimulation of adult rat cardiac myocytes. Dobretsov M; Hastings SL; Stimers JR J Physiol; 1998 Mar; 507 ( Pt 2)(Pt 2):527-39. PubMed ID: 9518710 [TBL] [Abstract][Full Text] [Related]
8. The use of beta3-adrenergic receptor agonists in the treatment of heart failure. Rasmussen HH; Figtree GA; Krum H; Bundgaard H Curr Opin Investig Drugs; 2009 Sep; 10(9):955-62. PubMed ID: 19705338 [TBL] [Abstract][Full Text] [Related]
9. Beta3-adrenoceptor agonist stimulation of the Na+, K+ -pump in rat skeletal muscle is mediated by beta2- rather than beta3-adrenoceptors. Murphy KT; Bundgaard H; Clausen T Br J Pharmacol; 2006 Nov; 149(6):635-46. PubMed ID: 17016512 [TBL] [Abstract][Full Text] [Related]
10. Expression and phosphorylation of the na-pump regulatory subunit phospholemman in heart failure. Bossuyt J; Ai X; Moorman JR; Pogwizd SM; Bers DM Circ Res; 2005 Sep; 97(6):558-65. PubMed ID: 16100047 [TBL] [Abstract][Full Text] [Related]
11. Intracellular Na(+) concentration is elevated in heart failure but Na/K pump function is unchanged. Despa S; Islam MA; Weber CR; Pogwizd SM; Bers DM Circulation; 2002 May; 105(21):2543-8. PubMed ID: 12034663 [TBL] [Abstract][Full Text] [Related]
15. Chronic amiodarone-induced inhibition of the Na+-K+ pump in rabbit cardiac myocytes is thyroid-dependent: comparison with dronedarone. Pitt AD; Fernandes C; Bewick NL; Hemsworth PD; Buhagiar KA; Hansen PS; Rasmussen HH; Delbridge L; Whalley DW Cardiovasc Res; 2003 Jan; 57(1):101-8. PubMed ID: 12504819 [TBL] [Abstract][Full Text] [Related]
16. alpha-Adrenergic effects on Na+-K+ pump current in guinea-pig ventricular myocytes. Wang Y; Gao J; Mathias RT; Cohen IS; Sun X; Baldo GJ J Physiol; 1998 May; 509 ( Pt 1)(Pt 1):117-28. PubMed ID: 9547386 [TBL] [Abstract][Full Text] [Related]
17. Beta-adrenergic stimulation does not regulate Na pump function in voltage-clamped ventricular myocytes of the rat heart. Ishizuka N; Berlin JR Pflugers Arch; 1993 Aug; 424(3-4):361-3. PubMed ID: 8105445 [TBL] [Abstract][Full Text] [Related]
18. "Don't flog the heart!" - development of specific drug therapies for heart failure. Rasmussen HH; Figtree G Crit Care Resusc; 2007 Dec; 9(4):364-9. PubMed ID: 18052902 [TBL] [Abstract][Full Text] [Related]
19. The first-in-man randomized trial of a beta3 adrenoceptor agonist in chronic heart failure: the BEAT-HF trial. Bundgaard H; Axelsson A; Hartvig Thomsen J; Sørgaard M; Kofoed KF; Hasselbalch R; Fry NA; Valeur N; Boesgaard S; Gustafsson F; Køber L; Iversen K; Rasmussen HH Eur J Heart Fail; 2017 Apr; 19(4):566-575. PubMed ID: 27990717 [TBL] [Abstract][Full Text] [Related]
20. [Cardiovascular effects of beta1 and beta3-adrenergic receptor autoantibodies in Lewis rat]. Montaudon E; Abdelkrim MA; Desfontis JC; Mallem MY Ann Cardiol Angeiol (Paris); 2014 Jun; 63(3):128-34. PubMed ID: 24861502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]